ArticleFrontiers in oncology2021

A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups.

Yuting Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.